# Effect of the Enteric Hormone Glucagon-Like Peptide (GLP-2) on the Intestinal Blood Flow in Patients With Short Bowel Syndrome

> **NCT00673751** · NA · UNKNOWN · sponsor: **Glostrup University Hospital, Copenhagen** · enrollment: 8 (estimated)

## Conditions studied

- Short Bowel Syndrome

## Interventions

- **DRUG:** GLP-2
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00673751
- **Lead sponsor:** Glostrup University Hospital, Copenhagen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 8 (ESTIMATED)
- **Last updated:** 2008-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00673751

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00673751, "Effect of the Enteric Hormone Glucagon-Like Peptide (GLP-2) on the Intestinal Blood Flow in Patients With Short Bowel Syndrome". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT00673751. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*